On Wednesday, November 4, 2020, Sartorius Korea Biotech delivered a letter of intent to the Incheon Free Economic Zone Authority regarding investment in research, development, and manufacturing facilities for the biopharmaceutical process sector in Songdo International City. The letter outlined a plan to invest KRW 120 billion (USD 100 million) to establish research, development, and production facilities for single-use bags and cell culture media in Songdo International City, and to cooperate with the Incheon Free Economic Zone Authority in disseminating advanced technologies for the biopharmaceutical process sector within the bio cluster. Sartorius is a global life science company that supplies equipment, consumables, and solutions for biopharmaceutical manufacturing processes.